Tandem Diabetes Care (TNDM) Stock: Buy, Sell, or Hold?
TNDM - Tandem Diabetes Care, Inc.
$17.11
-1.20 (-6.55%)
▼
5d:
-16.25%
30d:
-27.01%
90d:
+8.29%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When TNDM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: TNDM is down 16.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: TNDM is down 16.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: TNDM is currently trading at $17.11, which is considered oversold relative to its 30-day fair value range of $19.61 to $22.98. From a valuation perspective, the stock is trading at a discount (Forward PE: 100.2) compared to its historical average (207.3). Remarkably, the market is currently pricing in an annual earnings decline of 21.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, TNDM is in a strong downtrend. The price is currently testing key support at $17.07. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.6% recently.
Market Sentiment: TNDM scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $28.70 (+67.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TNDM is in a strong downtrend. The price is currently testing key support at $17.07. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.6% recently.
Market Sentiment: TNDM scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $28.70 (+67.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$19.61 -
$22.98
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.4%
Protect Your Profits
Holding TNDM? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.6%)
- BULLISH: Trading 67.7% below Wall St target ($28.70)
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$19.61 -
$22.98
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$17.07
Resistance Level
$22.30
Current Trend
Strong Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
100.23
Wall Street Target
$28.70
(+67.7%)
Revenue Growth (YoY)
5.8%
Earnings Growth (YoY)
-37.0%
Profit Margin
-6.1%
Valuation Discount vs History
-21.5% cheaper
PE vs Historical
100.2 vs 207.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-21.5%
(market-implied from PE analysis)
1-Year Target
$15.40
(-10%)
2-Year Target
$13.86
(-19%)
3-Year Target
$12.47
(-27%)
3-Yr Target (if PE normalizes)
(PE: 100→207)
$25.80
(+51%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 100.2 to 207.3
Stabilization Target:
$35.39
(+106.8%)
PE Expansion Potential:
+106.8%
Share & Embed Analysis
Last updated: September 11, 2026 10:08 PM ET
Data refreshes hourly during market hours. Next update: 11:08 PM
Data refreshes hourly during market hours. Next update: 11:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TNDM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark David Novara
SELL
187 shares
2026-03-17
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 40 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 44 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 52 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 56 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 41 HOLD |
Advanced TNDM Option Strategies
Professional options setups generated by AI based on today's TNDM price and gamma walls.
